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Restorative sleep predicts the resolution of chronic widespread
pain: results from the EPIFUND study
K. A. Davies1, G. J. Macfarlane2, B. I. Nicholl1, C. Dickens3, R. Morriss4, D. Ray5 and J. McBeth1
Objectives. Poor sleep is associated with chronic widespread pain (CWP). Conversely, good-quality sleep may play a role in the resolution of
pain symptoms. Sleep is a multidimensional construct, comprising a number of diverse components. The aims of the current study were to
examine the hypotheses that: (i) good sleep quality would predict the resolution of CWP, (ii) restorative sleep would predict the resolution of
CWP and (iii) that these relationships would be independent of confounding psychological factors.
Methods. Subjects in a population-based prospective study completed a pain questionnaire at baseline from which subjects with CWP were
identified. Baseline sleep was measured using the Estimation of Sleep Problems Scale which measures sleep onset, maintenance, early
wakening and restorative sleep. The questionnaire also contained scales examining psychosocial status. Subjects were followed up 15
months later and pain status was assessed.
Results. A total of 1061 subjects reported CWP at baseline of whom 679 (75% of eligible subjects) responded at follow-up. Of those, a total of
300 (44%) no longer satisfied criteria for CWP. Univariate analysis revealed that three of the four sleep components were associated with the
resolution of CWP: rapid sleep onset, odds ratio (OR)¼ 1.7, 95% CI 1.2, 2.5; absence of early wakening, OR¼ 1.6, 95% CI 1.1, 2.4; and
restorative sleep, OR¼ 2.7, 95% CI 1.5, 4.8. After adjusting for the effect of psychosocial factors, which may have confounded the
relationship, only restorative sleep (OR¼ 2.0, 95% CI 1.02, 3.8) was associated.
Conclusions. Self-reported restorative sleep was independently associated with the resolution of CWP and return to musculoskeletal health.
KEY WORDS: Sleep quality, Chronic widespread pain resolution, Restorative sleep.
Introduction
Chronic widespread pain (CWP) is the cardinal feature of
fibromyalgia. CWP impacts upon physical and psychological
well-being and has important long-term consequences including
an increased risk of incident cancer [1] and early mortality [2].
There is limited research examining the association between CWP
and sleep quality. However, a robust evidence base has demon-
strated an association between poor sleep quality and fibromyal-
gia. In a clinical population, 73% of fibromyalgia patients
reported some sleep disturbance [3]. Population-based studies
provide further support for the high prevalence of sleep problems
amongst individuals with fibromyalgia, with up to 99% of
fibromyalgia subjects reporting some form of sleep difficulty [4].
However, these studies have been cross-sectional and were unable
to determine whether the observed sleep disturbance preceded or
was a consequence of having chronic pain.
Data gathered using sleep diaries (which recorded the timing
and quality of sleep) indicated that, amongst women with
fibromyalgia, a night of poorer sleep was followed by a
significantly more painful day, and a more painful day was
followed by a night of poorer sleep [5]. We have previously
reported, in a population-based prospective study of subjects free
of CWP, that self-reported poor sleep increased the risk of new
symptom onset 15 months later [6]. Experimental research is also
supportive of a sequential link between sleep and pain. Induced
periods of night-time mini-arousal have been shown to induce
symptoms similar to those observed in subjects with CWP [7],
while, intriguingly, on removal of these arousal periods, the
induced pain symptoms resolved. Furthermore, sleep deprivation
studies have shown that in healthy volunteers poor sleep lowers
pressure pain threshold, whereas recovery sleep after sleep
deprivation increases pain thresholds [8]. Research supports a
reciprocal relationship between CWP and sleep quality, where
pain results in poor sleep which, in turn, increases pain and results
in the persistence of the disease [8]. Conversely, good-quality sleep
may play a role in the resolution of pain symptoms and the return
to musculoskeletal health.
Sleep is a multidimensional construct, comprising a number of
diverse components. Sleep problems usually include one or more
of the following complaints: delay of sleep onset, difficulty staying
asleep, waking too early and non-restorative sleep (waking feeling
unrefreshed). Non-restorative sleep is a prominent feature of the
sleep problems reported by patients with fibromyalgia [3, 9].
However, the relationship between non-restorative sleep and the
resolution of CWP is not known.
A number of psychological factors that are associated both
with sleep quality and pain may confound the relationship. For
example, depression and anxiety are both associated with poor
sleep quality and CWP [10–12]. As such, we will examine the
influence of potential confounders on the association between
sleep quality and the resolution of CWP.
The aims of the current study are to examine the hypotheses
that: (i) good sleep quality would predict the resolution of CWP;
(ii) restorative sleep would predict the resolution of CWP; and (iii)
these relationships would be independent of confounding psycho-
logical factors.
Methods
Design
Subjects were those who participated in a population-based
prospective study of pain. The sampling frame was all individuals
aged between 25 and 65 yrs who were registered at one of three
general practices in the north-west of England. Subjects completed
a questionnaire at baseline that assessed pain status from which
those with CWP (see subsequently) were identified. Sleep quality
was also assessed at baseline. A number of psychosocial factors
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are associated with CWP and also with sleep, and may have
confounded any relationship observed. To assess and allow us
to control for these potential confounders, the questionnaire
contained scales examining levels of psychosocial distress, somatic
symptom reporting and medical help-seeking behaviour. Fifteen
months after the baseline survey, subjects were sent a follow-up
questionnaire that assessed pain status. The study was approved
by the local NHS Research Ethics Committee.
Baseline questionnaire
Sleep quality. The four-item Estimation of Sleep Problems Scale
[13] was used to examine sleep quality. The scale asks about recent
problems with sleep and contains items on the most commonly
occurring symptoms of poor sleep quality: sleep onset (‘During
the past month did you have trouble falling asleep?’); sleep
maintenance (‘During the past month did you wake up several
times per night?’); early wakening (‘During the past month did
you have trouble staying asleep, including waking up far too
early?’); and non-restorative sleep (‘During the past month did
you wake up after your normal amount of sleep feeling tired and
worn out?’). Subjects indicate the number of days in the past
month that they have experienced difficulties in each of the four
sleep components on a 5-point scale ranging from 0 to 5 (0¼ 0
days; 1¼ 1–3 days; 2¼ 4–7 days; 3¼ 8–14 days; 4¼ 15–21 days;
5¼ 22–31 days). The scale has been used in previous studies of
CWP and fibromyalgia [14, 15]. The internal consistency co-
efficient for the scale was 0.79 [13].
Pain assessment. The questionnaire asked subjects about the
occurrence and chronicity of pain. Four-line drawings (blank
body manikins: front, back and sides) accompanied the pain
questions and subjects were asked to indicate site(s) of pain they
had experienced for 1 day or longer in the past month. These
methods have been used previously to determine the location and
duration of pain [16, 17]. Using the information on pain status,
CWP was defined based on the ACR definition in their criteria for
fibromyalgia [18]. These require that pain must have been present
for at least 3 months and be present in two contralateral areas of
the body, above and below the waist and in the axial skeleton.
Questionnaire: psychosocial assessment. A number of factors
associated with CWP may also be risk factors for poor sleep and
may therefore potentially confound any relationship observed.
Therefore, the baseline questionnaire also contained scales
assessing: psychological distress (General Health Questionnaire),
somatization (Somatic Symptom Checklist), anxiety and depres-
sion (Hospital Anxiety and Depression Scale) and health anxiety
and illness behaviour (Illness Attitude Scales).
Hospital Anxiety and Depression Scale. The Hospital
Anxiety and Depression (HAD) scale [19] examines levels of
anxiety and depression in the last week. The HAD contains a
seven-item depression subscale and a seven-item anxiety subscale.
Subjects rate each item on a four-point scale scored 0–3 with
higher scores associated with a higher probability of having a
depressive or anxiety disorder.
General Health Questionnaire. The 12-item version of the
General Health Questionnaire (GHQ) [20] was used to examine
levels of psychological distress. Each item has four possible
responses, for scoring purposes; these are dichotomized (0 or 1)
and the 12 scores added together to give a total GHQ score
between 0 and 12. Higher scores indicate higher levels of
psychological distress.
Somatic Symptoms Checklist. The Somatic Symptoms
Checklist (SSC) [21] was originally designed and validated as a
screening test for somatization disorder. The scale contains six
items (and an additional item for females regarding menstrual
cramps). Subjects are required to answer yes or no to questions
regarding the occurrence of symptoms (e.g. ‘Have you ever had
trouble breathing?’). Scores are summed to provide a total number
of somatic symptoms reported. One item, ‘have you ever had
difficulties swallowing or had an uncomfortable lump in your
throat that stayed with you for at least an hour?’, was excluded
from the analysis due to a high proportion of missing answers. To
avoid spurious association with CWP the item examining pain in
fingers and toes was also excluded.
Illness attitudes scales. The Illness Attitudes Scales (IAS) [22]
consist of two subscales: health anxiety and illness behaviour. The
health anxiety subscale contains 11 items (e.g. ‘are you worried
that you may get a serious illness in the future?’) which are scored
on a five-point scale (0–4) with total scores ranging from 0 to 44.
The illness behaviour scale contains six items (e.g. ‘how often do
you see a doctor?’) also scored on a five-point scale from 0 (‘No’)
to 4 (‘Most of the time’), with total scores ranging from 0 to 24.
Follow-up
All subjects who reported CWP at baseline, who agreed to further
contact from the study team and provided contact details, were
eligible for follow-up. Subjects were sent a questionnaire 15
months after they completed the baseline questionnaire. Pain
status was assessed using the same methodology as in the baseline
survey described above. Trained observers, who were blind to all
baseline data, determined pain status at follow-up and subjects
were classified into those with and without CWP.
Statistical analysis
The distribution of sleep scores was not Gaussian. Therefore, for
analysis the total sleep score was categorized into thirds based
upon the distribution of subjects’ scores, resulting in three equal-
sized groups for analysis. Similarly, the individual sleep compo-
nents (onset, maintenance, early wakening and non-restorative)
were categorized into thirds: ‘no sleep problems’ (reporting 0
days); ‘moderate level of sleep problems’ (1–7 days); and ‘high
level of sleep problems’ (8–31 days). Subjects classified as ‘high
level of sleep problems’ were classed as the referent group. We
used logistic regression to examine the association between
‘moderate sleep problems’ and ‘no sleep problems’ at baseline
and the resolution of CWP at follow-up, adjusting for the effects
of age and gender. We then examined the association between
each of the psychosocial variables and CWP resolution. For this
analysis, each of the psychosocial scales were categorized into
thirds based upon the distribution of subjects’ scores to form three
equal-sized groups with the highest third classed as the referent
group. Those psychosocial factors that were independently
associated with CWP resolution were included in a final multi-
variate logistic regression model that examined the association
between sleep quality components and CWP resolution.
The majority of the subjects whose CWP had resolved at
follow-up still reported some regional pain. To examine the
influence of this on the findings, subjects were stratified by pain
status at follow-up (‘no pain’ and ‘some pain’) and the multi-
variate model was re-run to determine whether the relationship
observed in the multivariate model was apparent for both groups.
Number of pain sites at baseline was added to the final model to
determine whether the observed relationship was confounded by
pain severity at baseline. The results are presented as odds ratios
(ORs) with 95% CI. All analyses were conducted using the
STATA statistical software (Texas, USA) [23].
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Results
Response rates
A total of 1061 subjects reported CWP at baseline and formed the
cohort for this study. Of those, 906 (85%) provided complete sleep
data, consent and contact details for follow-up. A total of 679
subjects returned the follow-up questionnaire and, after adjusting
for those who had moved or died and therefore could not receive a
questionnaire (n¼ 72), the response rate was 92% (Fig. 1).
Sleep quality and the resolution of CWP
A total of 300 (44%) subjects no longer satisfied criteria for CWP
at follow-up (Table 1). Subjects who reported symptom resolution
were younger than those whose CWP persisted. The groups did
not differ on gender.
Univariate analysis of total sleep scores revealed that compared
to those in the referent group (poor-quality sleep) subjects in the
lowest third, i.e. those reporting the best quality sleep, were 60%
more likely to have symptoms that resolved (OR¼ 1.6, 95% CI
1.1, 2.4).
Specific sleep components and resolution of CWP
Examining the independent sleep components revealed that three
of the four were significantly associated with the resolution of
CWP: rapid sleep onset (OR¼ 1.7, 95% CI 1.2, 2.5); absence
of early wakening (OR¼ 1.6, 95% CI 1.1, 2.4); and restorative
sleep (OR¼ 2.7, 95% CI 1.5, 4.8) (all analyses adjusted for age
and gender).
The role of confounding factors
In comparison with the CWP subjects whose pain persisted,
subjects whose CWP resolved had significantly lower baseline
levels of anxiety (HAD; P¼ 0.014), depression (HAD; P¼ 0.000),
psychological distress (GHQ; P¼ 0.033), somatic symptoms (SSC;
P¼ 0.000), illness behaviour (P¼ 0.000) and health anxiety (IAS;
P¼ 0.048) (all P-values Mann–Whitney rank sum).
Univariate logistic regression showed that scoring in the middle
or lowest third of each of the psychosocial factors, except health
anxiety, was associated with CWP resolution. In multivariate
analysis, illness behaviour independently predicted symptom
resolution (Table 2).
A final multivariate model examined the association between
the four sleep components and symptom resolution after adjusting
for psychosocial factors, age and gender (Table 3). Only
restorative sleep (OR¼ 2.0, 95% CI 1.02, 3.8) remained indepen-
dently associated with the resolution of CWP. Including the
number of pain sites at baseline did not influence the final model;
restorative sleep remained the only factor that was independently
associated with symptom resolution (OR¼ 2.0, 95% CI 1.00, 3.8).
The majority of subjects (n¼ 232, 77.7%) whose CWP had
resolved at follow-up still reported some regional pain and only 68
(23%) subjects were completely pain free. When stratified by
having ‘some pain’ or ‘no pain’ at follow-up, we found that the
association between restorative sleep and pain resolution was
similar between these two groups: pain free at follow-up,
OR¼ 1.9, 95% CI 0.7, 5.3; regional pain at follow-up,
OR¼ 1.8, 95% CI 0.9, 3.7.
Discussion
We have shown that, in this population of CWP subjects, self-
reported good-quality sleep is associated with the resolution of
symptoms and the return to musculoskeletal health. This study
examined the role of four constructs of good-quality sleep: sleep
onset; sleep maintenance; early wakening; and restorative sleep. In
univariate analyses, three of the four sleep components were
associated with the resolution of CWP: rapid sleep onset, absence
of early wakening and restorative sleep. However, after control-
ling for psychosocial factors only restorative sleep was associated.
There are a number of limitations to the current study. First,
78% of those subjects who were classified as having CWP that had
TABLE 1. Prevalence of symptom resolution by age and gender
Male Female
Age (yrs) n CWP resolved (n) % n CWP resolved (n) %
25–45 73 32 44 154 93 60
46–55 79 34 43 147 58 39
56–65 73 32 44 153 51 33
Total 225 98 – 454 202 –
TABLE 2. The association between psychological factors and CWP resolution,
adjusted for age and gender
Psychological
CWP
persisted
CWP
resolved
Univariate
model
Multivariate
model
factor Categories (n) (n) OR (95% CI) OR (95% CI)
HAD—depression 8–21 132 61 Referent Referent
4–7 127 113 2.0 (1.3, 3.0) 1.4 (0.8, 2.3)
0–3 117 120 2.2 (1.5, 3.4) 1.2 (0.7, 2.2)
HAD—anxiety 11–21 113 72 Referent Referent
7–10 123 96 1.3 (0.8, 1.9) 0.9 (0.5, 1.4)
0–6 138 128 1.5 (1.0, 2.3) 0.9 (0.6, 1.6)
GHQ 4–12 135 84 Referent Referent
1–3 79 60 1.3 (0.8, 1.9) 0.9 (0.5, 1.6)
0 156 151 1.6 (1.1, 2.3) 1.0 (0.6, 1.6)
Somatic symptoms 2–3 67 34 Referent Referent
1 159 104 1.4 (0.8, 2.2) 1.0 (0.6, 1.6)
0 142 156 2.4 (1.5, 3.9) 1.3 (0.8, 2.2)
Illness behaviour 12–24 153 57 Referent Referent
7–11 113 97 2.3 (1.5, 3.4) 2.0 (1.2, 3.1)
0–6 100 138 3.7 (2.5, 5.5) 3.2 (2.0, 5.1)
Health anxiety 15–44 118 73 Referent Referent
9–14 112 101 1.4 (0.9, 2.1) –
0–8 132 114 1.4 (0.95, 2.1) –
CWP at baseline
n=1061
Follow-up questionnaire sent
n=906 (85%)
Missing sleep data, refused 
further contact, moved or 
died before follow-up 
n=155 
Lost to follow-up n=227 (25%) 
(Moved=70; deceased=2; non-
responders=119; refusals=48)
Returned follow-up questionnaire
n=679 (75%)
CWP resolved
n=300
(44%)
CWP
n=379
(56%)
FIG. 1. Flow chart showing participation of subjects at follow-up.
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resolved at follow-up reported some regional pain. We were
concerned that perhaps we were predicting, not the resolution of
pain symptoms, but moving out of criteria for CWP. However, the
relationships between restorative sleep and having some pain or
being completely pain free at follow-up were identical. Reporting
some pain at follow-up did not alter the association between CWP
resolution and sleep quality. Although these associations are
strong, the CIs span unity, which is likely to be a result of the
smaller sample size in this stratified analysis [n¼ 432 (CWP
persist¼ 366, CWP resolve¼ 66) and n¼ 592 (CWP persist¼ 366,
CWP resolve¼ 226), respectively]. Second, pain severity at base-
line is an obvious potential confounder of the relationship. We did
not have a measure of pain severity at baseline. However, we
examined the extent of the pain by controlling for the number of
pain sites at baseline. The relationship between pain resolution
and restorative sleep persisted after controlling for number of pain
sites. Third, this study identified a group of subjects who had
CWP at baseline and followed them up 15 months later. We may
have missed subjects whose pain had resolved and who then went
on to develop new pain before we contacted them at the
follow-up. However, given that the definition of CWP requires
having pain for more than 3 months it seems probable that only a
small proportion of subjects could have experienced a resolution
of their CWP and then development of new CWP in that time
frame. There were a number of non-responders at baseline and
follow-up. For non-response to influence the associations, we
have reported you would have to hypothesize that factors
associated with responding to a postal survey would confound
the association between sleep and pain resolution. This seems
unlikely. Finally, this study used a self-report measure which may
not accurately reflect actual sleep quality. For example, chronic
musculoskeletal pain patients have been shown to under-estimate
total sleep time and over-estimate sleep onset latency [24]. Further
research using both objective and subjective measures of sleep
quality should address this issue because understanding the nature
of sleep disturbance in these individuals has implications for the
development of effective treatment interventions.
The results of our study are consistent with randomized
controlled trials of sodium oxybate, a drug used to prevent the
onset of cataplexy and daytime fatigue, and pregabaline, a drug
used to treat pain and anxiety, in fibromyalgia. Both drugs
produce refreshing sleep and reduced pain in fibromyalgia, and
increase slow wave sleep on polysomnography [25, 26, 27]. Thus
experimental studies support the link between restorative sleep
and symptomatic improvement in fibromyalgia and CWP, but
these studies also indicate that the restoration of refreshing sleep
may be achieved through different pharmacological and
pathophysiological mechanisms. It is not clear whether refreshing
sleep is a mechanism for recovery or a marker of recovery but
either way restoration of refreshing sleep may be a clinically useful
sign of impending improvement in fibromyalgia or CWP.
As the weight of evidence does suggest that sleep is associated
with the onset and resolution of CWP, it is interesting and
potentially important to speculate on the possible mechanisms.
Good sleep has been shown to buffer the relationship between
pain and negative affect [28]. Subjects with fibromyalgia or RA
recorded sleep quality, daily stressful events, pain and negative
and positive affect (mood) at 2½-h intervals during the day. In
subjects who reported poor sleep there was a strong association
between momentary increases in pain and increases in negative
affect. Whereas, there was no association between pain and
negative affect in subjects who reported good-quality sleep.
Hamilton et al. [28] suggested that good-quality or restorative
sleep acts as a biobehavioural resource that minimizes allostatic
load. The majority of the studies examining the association
between sleep disruption and pain have been descriptive and it is
unclear what biological mechanisms underpin the association [29].
In a recent review, a number of potential biological mechanisms
were identified [29]. It was suggested that rapid eye movement
(REM) sleep deprivation may render the serotonin system
functionally unable to support pain inhibition produced by
opioidergic activation. Furthermore, sleep is an important com-
ponent of homeostasis and sleep deprivation affects a number of
circadian rhythms, including the hypothalamic pituitary adrenal
(HPA) axis [30], alterations that are associated with CWP [31].
To conclude, the present population-based prospective study
has demonstrated that sleep is associated with the resolution of
CWP. Restorative sleep was independently associated with the
resolution of CWP and return to musculoskeletal health. If there
is a bi-directional relationship between sleep and the experience of
pain symptoms, this would support the development of interven-
tions focusing on improving sleep in CWP sufferers. Although we
cannot infer a causal relationship based on these data, the role of
sleep quality in the resolution of symptoms warrants further
investigation since interventions targeted at sleep problems could
form one component of management.
TABLE 3. The association between sleep and CWP resolution for both total sleep score and the individual components of sleep, adjusted for age, gender and psychosocial
scores
CWP persisted CWP resolved
Univariate
model (crude)
Univariate model adjusting
for age and gender
Multivariate model adjusting for age,
gender and psychosocial factors
Sleep factor Sleep score (n) (n) OR (95% CI) OR (95%CI) OR (95% CI)
Overall 15–20 125 76 Referent Referent –
8–14 128 97 1.2 (0.8, 1.8) 1.2 (0.8, 1.8) –
0–7 126 127 1.7 (1.1, 2.4) 1.6 (1.1, 2.3) –
No. of days of sleep problems
Onset 8–31 159 90 Referent Referent Referent
1–7 113 111 1.7 (1.2, 2.5) 1.7 (1.2, 2.5) 1.4 (0.9, 2.2)
0 107 99 1.6 (1.1, 2.4) 1.7 (1.2, 2.5) 0.99 (0.6, 1.6)
Maintenance 8–31 224 158 Referent Referent Referent
1–7 117 103 1.2 (0.9, 1.7) 1.2 (0.9, 1.7) 1.1 (0.7, 1.9)
0 38 39 1.5 (0.9, 2.4) 1.4 (0.8, 2.3) 0.8 (0.4, 1.7)
Early wakening 8–31 192 134 Referent Referent Referent
1–7 118 85 1.0 (0.7, 1.5) 0.98 (0.7, 1.4) 0.7 (0.4, 1.1)
0 69 81 1.7 (1.1, 2.5) 1.6 (1.1, 2.4) 1.1 (0.6, 2.0)
Restorative 8–31 241 170 Referent Referent Referent
1–7 113 91 1.1 (0.8, 1.6) 1.2 (0.8, 1.6) 0.9 (0.6, 1.4)
0 25 39 2.2 (1.3, 3.8) 2.7 (1.5, 4.8) 2.0 (1.0, 3.8)
Rheumatology key messages
 Good-quality sleep was associated with the resolution of CWP.
 Restorative sleep was independently associated with the resolu-
tion of pain symptoms.
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